1.

REFERENCIAS BIBLIOGRAFICAS

1.-Vasan RS. Biomarkers of cardiovasculardisease. Molecular basis and

practical considerations. Circulation 2010;113:2335- 2362. [Acceso 28 de
julio

de

2014].

Disponible

en:

http://circ.ahajournals.org/content/113/19/2335.full.

2.-Alpert JS, Thygesen K, White HD, Jaffe AS. Implications of the universal
definition of myocardial infarction. Nat Clin Pract Cardiovasc Med
2010;5(11):678-9.

[Acceso

28

de

julio

de

2014].

Disponible

en:

http://www.ncbi.nlm.nih.gov/pubmed/18779833.

3.-Van deWerf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et

al. Management of acute myocardial infarction in patients presenting with
persistent ST-segment elevation: the Task Force on the Management of STSegment Elevation Acute Myocardial Infarction of the European Society of
Cardiology. Eur Heart J. 2008;29:2909-45. [Acceso 28 de julio de 2014].
Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/19004841.

4.-Terkelsen CJ, Lassen JF, Norgaard BL, Gerdes JC, Jensen T,Gotzsche LB,
et al. Mortality rates in patients with ST-elevations. Non-ST-elevation acute
myocardial infarction: observations from an unselected cohort. Eur Heart J
2009;

26:18-26.

[Acceso

28

de

julio

de

2014].

Disponible

en:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724561/.

5.-Archbold RA, Balami D, Al-Hajiri A. Hemoglobin concentration is an

independent determinant of heart failure in acute coronary syndromes:
cohort analysis of 2310 patients. Am Heart J. 2008Dec;152(6):1091-5.

[Acceso

28

de

julio

de

2014].

Disponible

en:

http://www.ncbi.nlm.nih.gov/pubmed/17161058.

6.-Da Silveira A, Ribeiro R, Rossini A. Association of anemia with clinical

outcomes

in

stable

2009;19(1):21-6.

coronary

[Acceso

28

artery
de

julio

disease.
de

Coron

2014].

Artery

Dis.

Disponible

en:

http://www.ncbi.nlm.nih.gov/pubmed/18281811.

7.-Nabais S, Gaspar A, Costa J. Prognostic impact of hemoglobin drop

during hospital stay in patients with acute coronary syndromes. Rev Port
Cardiol. 2009 Apr;28(4):383-95. [Acceso 28 de julio de 2014]. Disponible
en: http://www.ncbi.nlm.nih.gov/pubmed/19634496.

8.-Wang CH, Jin XF, Fang Q. [Effects of hemoglobin levels on long-term

prognosis in patients with acute ST-segment elevation myocardial
infarction

undergoing

primary

percutaneous

coronary

intervention].

Zhonghua Yi Xue Za Zhi. 2011 Nov 15;91(42):3003-6. [Acceso 28 de julio

de 2014]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22333029.

9.-Boliska S, Sobkowicz B, Zaniewska J. The significance of anaemia in

patients with acute ST-elevation myocardial infarction undergoing primary
percutaneous coronary intervention. Kardiol Pol. 2011;69(1):33-9. [Acceso
28

de

julio

de

2014].

Disponible

en:

http://www.ncbi.nlm.nih.gov/pubmed/21267962.

10.-Ferreira M, Antnio N, Gonalves F.[Hemoglobin: simply a laboratory

value or a powerful predictor of risk in patients with acute coronary

syndrome?]. Rev Port Cardiol. 2012 Feb;31(2):121-31. [Acceso 28 de julio

de 2014]. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22244550.
11.-Dndar

C, Oduncu

V, Erkol

A.

In-hospital

prognostic

value

of

hemoglobin levels on admission in patients with acute ST segment

elevation myocardial infarction undergoing primary angioplasty. Clin Res
Cardiol. 2012 Jan;101(1):37-44. [Acceso 28 de julio de 2014]. Disponible
en: http://www.ncbi.nlm.nih.gov/pubmed/21931965.

12.-Puurunen M, Kiviniemi T, Nammas W. Impact of anaemia on clinical

outcome in patients with atrial fibrillation undergoing percutaneous
coronary intervention: insights from the AFCAS registry. BMJ Open. 2014
May

13;4(5).

[Acceso

28

de

julio

de

2014].

Disponible

en:

http://content.onlinejacc.org/article.aspx?articleid=1855298.

13.-Tomaszuk A, Boliska S, Modawska E. Does admission anaemia still

predict mortality six years after myocardial infarction?. Kardiol Pol.
2014;72(6):488-93. [Acceso 28 de

julio de 2014].

Disponible en:

http://www.ncbi.nlm.nih.gov/pubmed/24526561.

14.-Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, FernandezAviles F, et al. Guidelines for the diagnosis and treatment of non-STsegment elevation acute coronary syndromes. Eur Heart J. 2010;28:1598660.
15.-Braunwald E Heart disease: A textbook of cardiovascular medicine. 7
ed. Philadelphia: W.B. Saunders, 2011.
16.-Alpert JS, Thygesen K, Antman EM, Bassand JP. Myocardial infarction
redefineda consensus document of The Joint European Society of
Cardiology/American College of Cardiology Committee for the redefinition
of myocardial infarction. Eur Herat J 2010;21:5-9.

17.-Hamm C, Mollmann H, Bassand J, Van deWerf

F. Acute coronary

syndrome. En: Camm AJ, Luscher TF, Serruys PW, editores. The ESC
Textbook of Cardiovascular Medicine. 2.a ed. Oxford: Oxford University
Press; 2011.
18.-Hamm W. Gua de prctica clnica de la ESC para el manejo del
sndrome coronario agudo en pacientes sin elevacin persistente del
segmento ST. Rev Esp Cardiol. 2012;65(2):173.e1-e55.
19.-Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE
Jr et al. ACC/AHA 2010 guidelines for the management of patients with
unstable angina/non-ST-Elevation myocardial infarction: a report of the
American College of Cardiology/American Heart Association Task Force on
Practice Guidelines. J Am Coll Cardiol. 2010;50:e1-e157.
20.-Kumar A, Canon C. Acute Coronary Syndromes: Diagnosis and
Management, Part I. Mayo Clin. Proc. 2010; 84 (10): 917 938.
21.-Kleinbaum DG. Statistics in the health sciences: Survival analysis.
New York: Springer-Verlag publishers; 2011.p78.
22.-Declaracin de Helsinki de la Asociacin Mdica Mundial. Adoptada
por la 18 Asamblea Mdica Mundial, Helsinki, Finlandia, junio de 1964 y
enmendada por la 29 Asamblea Mdica Mundial, Tokio, Japn, octubre de
1975, la 35 Asamblea Mdica Mundial, Venecia, Italia, octubre de 1983 y
la 41 Asamblea Mdica Mundial, Hong Kong, septiembre de 2010.
23.-Ley general de salud. N 26842. Concordancias: D.S.N 007-98-SA.
Peru: 20 de julio de 2012.

VI. ANEXOS
ANEXO N 01
Anemia como factor de riesgo para mortalidad en pacientes con
Sndrome Coronario Agudo en el Hospital Beln de Trujillo.

PROTOCOLO DE RECOLECCION DE DATOS

Fecha
I.

DATOS GENERALES:
1.1. Nmero de historia clnica: _______________
1.2. Nombres y apellidos: _______________________________________
1.3. Edad: _______ aos

II: VARIABLE DEPENDIENTE:

Mortalidad hospitalaria
III.-VARIABLE INDEPENDIENTE:
Valores al ingreso.

IV.-DIAGNOSTICO FINAL: